AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in AIM ImmunoTech Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- −2 vs. Q3 2025
- Shares held
- 106.0K
- −1.27K (−1.2%) vs. Q3 2025
- Total value
- $119.8K
- −$174.1K (−59.2%) vs. Q3 2025
- New holders
- 2
- 5 more added
- Sold out
- 4
- 0 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $325.6K |
| Q1 2026 | 18 | $102.8K |
| Q4 2025 | 13 | $119.8K |
| Q3 2025 | 15 | $293.9K |
| Q2 2025 | 12 | $104.8K |
| Q1 2025 | 34 | $590.0K |
| Q4 2024 | 35 | $919.3K |
| Q3 2024 | 33 | $2.43M |
| Q2 2024 | 36 | $3.15M |
| Q1 2024 | 33 | $1.93M |
| Q4 2023 | 38 | $1.83M |
| Q3 2023 | 38 | $1.97M |
| Q2 2023 | 34 | $3.01M |
| Q1 2023 | 36 | $2.05M |
| Q4 2022 | 39 | $1.67M |
| Q3 2022 | 38 | $3.36M |
| Q2 2022 | 40 | $4.68M |
| Q1 2022 | 38 | $7.12M |
| Q4 2021 | 43 | $6.86M |
| Q3 2021 | 38 | $14.7M |
| Q2 2021 | 39 | $15.5M |
| Q1 2021 | 38 | $16.8M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding AIM ImmunoTech Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DRW Securities, LLC | 69,545 | $78.6K | 0.01% | +26,254+60.6% | Added |
| Vanguard Group Inc | 17,502 | $19.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 17,376 | $19.6K | 0.00% | +1,190+7.4% | Added |
| Morgan Stanley | 864 | $976 | 0.00% | +1+0.1% | Added |
| UBS Group AG | 379 | $428 | 0.00% | +75+24.7% | Added |
| Community Bank, N.A. | 132 | $147 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 125 | $141 | 0.00% | +125 | New |
| Bank of America Corp | 28 | $32 | 0.00% | +1+3.7% | Added |
| Advisor Group Holdings, Inc. | 15 | $16 | 0.00% | 00.0% | Unchanged |
| Hoey Investments, Inc | 10 | $12 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Intesa Sanpaolo Wealth Management | 1 | $1 | 0.00% | +1 | New |
| Sabby Management, LLC | 0 | $0 | 0.00% | −28,855−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −4−100.0% | Sold out |